News

Success of the second symposium of the Oncobell research program

This Monday and Tuesday, September 19 and 20, the second Oncobell Symposium was held in the auditorium of the Bellvitge University Hospital. Under the slogan “building bridges between science, medicine and people” the congress is a forum to discuss the latest advances in basic and clinical research with top-level cancer professionals

Leer más

IDIBELL researchers analyze the evidence of iron supplementation in chronic heart failure

They have shown that intravenous iron administration improves the quality of life and prognosis in patients with heart failure and ventricular dysfunction.

Leer más

The IDIBELL-Ins Bellvitge Tandem opens the academic year with the inauguration of new scientific instruments for the secondary school laboratory

During the academic year that is beginning, the Tandem will continue educational projects that have been successful in recent years, such as the production of Life & Science magazine, the European Stars Game project, the Women of Science series, or the implementation of new laboratory practices in charge of the URIB

Leer más

Access to quality medical and emotional information during breast cancer through digital platforms could reduce patient discomfort

Misinformation about the disease is one of the most stressful factors for patients. For this reason, creating quality content could help maintain emotional well-being.

Leer más

A study with IDIBELL participation validates the effectiveness of biological treatments in severe asthma cases

The multicenter study in real life at the state level has been carried out with patients with severe asthma from a dozen hospitals and its main conclusion is that biological therapy is effective in both cases

Leer más

The age at onset of multiple sclerosis has increased over the last decades

An IDIBELL and the Bellvitge University Hospital study has detected that the age at which the first symptoms appear has progressively increased from 1970 to 2019.

Leer más

An IDIBELL study identifies the mechanisms by which NOX4 acts as a molecular brake on liver cancer

The work shows that in a NOX4 low activity situation, liver cancer cells reprogram the metabolism, causing oxidative stress, which favors tumor progression.

Leer más

A clinical trial with IDIBELL participation confirms the benefits of a new drug in heart failure

Dapagliflozin significantly reduces the risk of cardiovascular death and hospitalizations for heart failure (HF).

Leer más

A new endometrial cancer screening test that can be done at home

It is an epigenetic test capable of detecting between 90 and 100% of cases of endometrial cancer. This new rapid and non-invasive method can be performed: on cervical cytology samples obtained in the doctor’s office, and on vaginal self-samples collected at home.

Leer más
Scroll to Top